Israel Nuclear Medicine Therapeutics Market (2025-2031) | Companies, Growth, Outlook, Size & Revenue, Industry, Share, Analysis, Segmentation, Competitive Landscape, Value, Trends, Forecast

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Nuclear Medicine Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 Israel Nuclear Medicine Therapeutics Market - Industry Life Cycle

3.4 Israel Nuclear Medicine Therapeutics Market - Porter's Five Forces

3.5 Israel Nuclear Medicine Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F

3.6 Israel Nuclear Medicine Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing prevalence of cancer and other chronic diseases in Israel, driving the demand for nuclear medicine therapeutics.

4.2.2 Technological advancements in nuclear medicine imaging and therapy, leading to a wider adoption of nuclear medicine therapeutics.

4.2.3 Growing investments in healthcare infrastructure and RD activities in Israel, fostering the development and accessibility of nuclear medicine therapeutics.

4.3 Market Restraints

4.3.1 Stringent regulatory requirements and approval processes for nuclear medicine therapeutics in Israel, leading to delays in market entry.

4.3.2 High costs associated with nuclear medicine therapeutics, limiting affordability and accessibility for patients.

6.1 Israel Nuclear Medicine Therapeutics Market, By Type

6.1.1 Overview and Analysis

6.1.2 Israel Nuclear Medicine Therapeutics Market Revenues & Volume, By Type, 2021- 2031F

6.1.3 Israel Nuclear Medicine Therapeutics Market Revenues & Volume, By Alpha Emitters, 2021- 2031F

6.1.4 Israel Nuclear Medicine Therapeutics Market Revenues & Volume, By Beta Emitters, 2021- 2031F

6.1.5 Israel Nuclear Medicine Therapeutics Market Revenues & Volume, By Brachy therapy, 2021- 2031F

6.2 Israel Nuclear Medicine Therapeutics Market, By Application

6.2.1 Overview and Analysis

6.2.2 Israel Nuclear Medicine Therapeutics Market Revenues & Volume, By Oncology, 2021- 2031F

6.2.3 Israel Nuclear Medicine Therapeutics Market Revenues & Volume, By Cardiology, 2021- 2031F

6.2.4 Israel Nuclear Medicine Therapeutics Market Revenues & Volume, By Thyroid, 2021- 2031F

6.2.5 Israel Nuclear Medicine Therapeutics Market Revenues & Volume, By Other Applications, 2021- 2031F

7.1 Israel Nuclear Medicine Therapeutics Market Export to Major Countries

7.2 Israel Nuclear Medicine Therapeutics Market Imports from Major Countries

8.1 Number of new clinical trials and research studies conducted on nuclear medicine therapeutics in Israel.

8.2 Adoption rate of nuclear medicine imaging techniques in diagnostic procedures across healthcare facilities in Israel.

8.3 Number of partnerships and collaborations between Israeli healthcare institutions and international pharmaceutical companies for the development and commercialization of nuclear medicine therapeutics.

9.1 Israel Nuclear Medicine Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F

9.2 Israel Nuclear Medicine Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F

10.1 Israel Nuclear Medicine Therapeutics Market Revenue Share, By Companies, 2024

10.2 Israel Nuclear Medicine Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters